Cataract can nowadays be treated effectively by replacing the clouded lens by an artificial intraocular lens. However, the capability of accommodation is lost and secondary cataract may occur. Developing an injectable lens into the capsular bag to maintain accommodation, and to prevent secondary cataract by drug delivery from the lens material, it is important to know if potential constituents of the artificial lens or antiproliferative drugs can cross the capsular bag membrane and affect adjacent tissue. In this work human anterior lens capsules were used to determine the molecular weight cut off using fluorescent dextrans of different size and the permeability of antiproliferative drugs. The lens capsules were mounted into diffusion chambers and the amount of the permeated substances was determined after 24 h of incubation. The molecular weight cutoff was found to be at 163 kDa. The apparent permeability coefficients for actinomycin D and methotrexate were in the range of 5-7×10
Introduction
Cataract is the most common cause of reversible blindness worldwide, accounting for nearly half of all cases of blindness [1] . It can be corrected easily by replacing the clouded lens by artificial intraocular lenses. However, the capability of accommodation is lost. Therefore a lens injectable into the sustained capsular bag shall be developed to maintain accommodation [2] . To prevent further secondary cataract anti-proliferative drugs might be incorporated into the lens material. Incubation of human anterior lens capsule specimens with the antiproliferative drugs actinomycin D and methotrexate reduced the number of viable lens epithel cells dramatically and using a mixture of both showed no secondary cataract formation four months after rigid lens implantation in rabbits [3] . For this reasons it is important to know whether artificial lens constituents or drugs can escape the capsular bag and possibly damage adjacent tissue.
Methods

Chemicals
To assess the molecular weight cutoff (MWCO) of the anterior lens capsule, sodium fluorescein (376.27 g/mol) and fluorescent dextrans with different average molecular weights (10, 40, 150 and 500 kDa) were used as model substances and non-fluorescent dextrans of corresponding molecular weight as counterparts preventing osmotic effects (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), all dissolved at 1×10 -5 mol/l in PBS. The antiproliferative drugs actinomycin D (1255.42 g/mol) (Sigma-Aldrich) and methotrexate (454.44 g/mol) (Ubichem Ltd., Eastleigh, Hampshire, UK) were used to test their permeability through the lens capsule, dissolved at 1×10 -5 mol/l in deionized water.
Human anterior lens capsules
Human anterior lens capsules derived from routine cataract surgeries were placed in culture medium immediately after resection (Image 1).
Image 1:
Specimen of a human anterior lens capsule in culture medium.
Before the permeability experiments, the lens capsules were examined by light microscopy and should not contain any breaks or injuries in the diffusion area, and briefly placed into sterile deionized water for decellularization.
Permeability experiments
The experiments were performed in a PMMA two compartment-diffusion chamber, each with a capacity of about 1.5 ml, separated by the lens capsule specimen (Image 2).
The permeation area of the lens capsules was 0.01cm². Each chamber could be filled and sampled from via sampling channels, which were sealed by plastic pegs during incubation (not shown).
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Image 2: Simplified depiction of the diffusion chamber.
Assessing the MWCO the donor compartment was filled with the fluorescent dextrans in PBS, the acceptor compartment was filled with PBS or the non-fluorescent dextrans of corresponding molecular weight in PBS to maintain a constant pH value. Investigating drug permeation through the lens capsule, the donor compartment was filled with actinomycin D or methotrexate in ultrapure water, the acceptor compartment was filled with sterile deionized water. The chambers were incubated for 24 h at 37°C.
Determination of concentration of substances following the permeability experiments
After incubation, the contents of the acceptor compartment chamber were removed and their volume and their concentration determined. In case of assessing the MWCO fluorescence of the samples was measured in a microplate fluorescence reader with excitation wavelength at 485 nm and emission wavelength at 520 nm (FLUOstar OPTIMA, BMG Labtech, Offenburg, Germany) and concentrations calculated using calibration curves from 0 to 10 µmol/l of fluorescent substance. In case of actinomycin D and methotrexate the concentrations of each sample were determined by HPLC. For each drug, a Chromolith® FastGradient RP-18e 50-2 column (Merck KGaA, Darmstadt, Germany) with a particle size of 5 µm and a dimension of 100×4,6 mm² was used. For calibration, standards of these drugs were used with concentrations of 0.1, 0.5, 1.0, 2.0, 5.0, and 10.0 µg/ml.
Calculation of the apparent permeability coefficient
To determine the apparent permeability coefficient (P app ) of the fluorescent substances and the drugs, the following equation was used [4, 5] :
with ∆Q representing the concentration difference of the acceptor compartment after the time period ∆t, A being the permeation area of the lens capsule and C 0 denoting the initial drug concentration in the donor compartment. Masses were assessed with the aid of the determined volumes, the known molecular weights and the detected concentrations. Values are given as means ± SEM.
Results
The apparent permeability coefficient dropped with increasing decimal logarithm of fluorescent substance molecular weight (MW) (Image 3). This decline was linear from 0.376 to 40 kDa (R²=0.999) and leveled off at 150 and 500 kDa. This residual permeabilities may be due a small sized population of the average molecular weight FITC-dextrans being capable to enter the matrix pores and to cross the lens capsule [6] . The linear regression of the P app from 0.376 to 40 kDa produced an intercept on the abscissa at 2.08, indicating the molecular weight cut off of human anterior lens capsule at 120.11 kDa. The anterior lens capsule was found to be permeable for both actinomycin D and methotrexate. Their apparent permeability coefficients are shown in Table 1 . They are located between the values of 0.376 and 10 kDa, corresponding to their molecular weights. 
Conclusion
Our data confirm a declining permeability of the lens capsule for FITC-dextrans with increasing moleclular weight [6, 7] . Further antiproliferative drugs can permeate the anterior lens capsule in their free form. To avoid or minimize an escape from the capsular bag, artificial injectable lens constituents have to be bound firmly or to form large polymers which are retained within the capsular bag. The drug release from the capsular bag should be designed in a way to yield a drug concentration outside the capsular bag below its cytotoxicity (EC 50 ).
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